Molecular insights into Crimean-Congo hemorrhagic fever virus

Viruses

Volumn 8, Issue 4, 2016, Pages

  Zivcec, Marko ^a   Scholte, Florine E M ^a   Spiropoulou, Christina F ^a   Spengler, Jessica R ^a   Bergeron, Éric ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Crimean Congo hemorrhagic fever; Pathogenesis; Reverse genetics; Tick borne virus; Viral hemorrhagic fever

Indexed keywords

CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS; PATHOGENESIS; VIRUS REPLICATION; CRIMEAN CONGO HEMORRHAGIC FEVER; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; GENOMICS; HUMAN; METABOLISM; NAIROVIRUS; PHYSIOLOGY; TRANSMISSION; VIROLOGY; VIRUS ENTRY; VIRUS GENOME; VIRUS RELEASE;

VIRAL PROTEIN;

GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; GENOMICS; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; TRANSCRIPTION, GENETIC; VIRAL PROTEINS; VIRUS INTERNALIZATION; VIRUS RELEASE; VIRUS REPLICATION;

EID: 84964267985     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v8040106     Document Type: Review

References (125)

1. Ergönül, Ö. Crimean-Congo haemorrhagic fever. Lancet Infect. Dis. 2006, 6, 203-214.
2. Whitehouse, C. A Crimean-Congo hemorrhagic fever. Antivir. Res. 2004, 64, 145-160. [CrossRef]
3. Bente, D.A, Forrester, N.L, Watts, D.M, McAuley, A.J, Whitehouse, C.A, Bray, M. Crimean-Congo hemorrhagic fever: History, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antivir. Res. 2013, 100, 159-189. [CrossRef] [PubMed]
4. Vorou, R, Pierroutsakos, I.N, Maltezou, H.C. Crimean-Congo hemorrhagic fever. Curr. Opin. Infect. Dis. 2007, 20, 495-500. [CrossRef] [PubMed]
5. Hoogstraal, H. The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J. Med. Entomol. 1979, 15, 307-417. [CrossRef] [PubMed]
6. Wolfel, R, Paweska, J.T, Petersen, N, Grobbelaar, A.A, Leman, P.A, Hewson, R, Georges-Courbot, M.-C, Papa, A, Günther, S, Drosten, C. Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients. Emerg. Infect. Dis. 2007, 13, 1097-1100. [CrossRef] [PubMed]
7. Papa, A, Drosten, C, Bino, S, Papadimitriou, E, Panning, M, Velo, E, Kota, M, Harxhi, A, Antoniadis, A. Viral load and hemorrhagic fever. Emerg. Infect. Dis. 2007, 13, 805-806. [CrossRef] [PubMed]
8. Ergonul, O, Tuncbilek, S, Baykam, N, Celikbas, A, Dokuzoguz, B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J. Infect. Dis. 2006, 193, 941-944. [CrossRef] [PubMed]
9. Ergonul, O, Celikbas, A, Baykam, N, Eren, S, Dokuzoguz, B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: Severity criteria revisited. Clin. Microbiol. Infect. 2006, 12, 551-554. [CrossRef] [PubMed]
10. Duh, D, Saksida, A, Petrovec, M, Ahmeti, S, Dedushaj, I, Panning, M, Drosten, C, Avsic-Zupanc, T. Viral load as predictor of Crimean-Congo hemorrhagic fever outcome. Emerg. Infect. Dis. 2007, 13, 1769-1772. [CrossRef] [PubMed]
11. Yilmaz, G, Koksal, I, Topbas, M, Yilmaz, H, Aksoy, F. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: Severity prediction criteria. J. Clin. Virol. 2010, 47, 361-365. [CrossRef] [PubMed]
12. Yesilyurt, M, Gul, S, Ozturk, B, Kayhan, B.C, Celik, M, Uyar, C, Erdogan, F. The early prediction of fatality in Crimean Congo hemorrhagic fever patients. Saudi Med. J. 2011, 32, 742-743. [PubMed]
13. Weber, F, Mirazimi, A. Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis. Cytokine Growth Factor Rev. 2008, 19, 395-404. [CrossRef] [PubMed]
14. Saksida, A, Duh, D, Wraber, B, Dedushaj, I, Ahmeti, S, Avsic-Zupanc, T. Interacting roles of immune mechanisms and viral load in the pathogenesis of Crimean-Congo hemorrhagic fever. Clin. Vaccine Immunol. 2010, 17, 1086-1093. [CrossRef] [PubMed]
15. Papa, A, Bino, S, Velo, E, Harxhi, A, Kota, M, Antoniadis, A. Cytokine levels in Crimean-Congo hemorrhagic fever. J. Clin. Virol. 2006, 36, 272-276. [CrossRef] [PubMed]
16. Onguru, P, Dagdas, S, Bodur, H, Yilmaz, M, Akinci, E, Eren, S, Ozet, G. Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality. J. Clin. Lab. Anal. 2010, 24, 163-166. [CrossRef] [PubMed]
17. Cevik, M.A, Erbay, A, Bodur, H, Gülderen, E, Baştuğ, A, Kubar, A, Akinci, E. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: Predictors of fatality. Int. J. Infect. Dis. 2008, 12, 374-379. [CrossRef] [PubMed]
18. Cevik, M.A, Erbay, A, Bodur, H, Eren, S.S, Akinci, E, Sener, K, Ongürü, P, Kubar, A. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin. Infect. Dis. 2007, 45, e96-e100. [CrossRef] [PubMed]
19. Burt, F.J, Swanepoel, R, Shieh, W.J, Smith, J.F, Leman, P.A, Greer, P.W, Coffield, L.M, Rollin, P.E, Ksiazek, T.G, Peters, C.J, et al. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch. Pathol. Lab. Med. 1997, 121, 839-846. [PubMed]
20. Peyrefitte, C.N, Perret, M, Garcia, S, Rodrigues, R, Bagnaud, A, Lacote, S, Crance, J.-M, Vernet, G, Garin, D, Bouloy, M, et al. Differential activation profiles of Crimean-Congo hemorrhagic fever virus- and Dugbe virus-infected antigen-presenting cells. J. Gen. Virol. 2010, 91, 189-198. [CrossRef] [PubMed]
21. Connolly-Andersen, A.-M, Douagi, I, Kraus, A.A, Mirazimi, A. Crimean Congo hemorrhagic fever virus infects human monocyte-derived dendritic cells. Virology 2009, 390, 157-162. [CrossRef] [PubMed]
22. Connolly-Andersen, A.-M, Moll, G, Andersson, C, Akerström, S, Karlberg, H, Douagi, I, Mirazimi, A. Crimean-Congo hemorrhagic fever virus activates endothelial cells. J. Virol. 2011, 85, 7766-7774. [CrossRef] [PubMed]
23. ICTV. Virus Taxonomy 2014. Available online: http://www.ictvonline.org/virusTaxonomy.asp?bhcp=1 (accessed on 15 April 2016).
24. Hewlett, M.J, Pettersson, R.F, Baltimore, D. Circular forms of Uukuniemi virion RNA: An electron microscopic study. J. Virol. 1977, 21, 1085-1093. [PubMed]
25. Devignot, S, Bergeron, E, Nichol, S, Mirazimi, A, Weber, F. A Virus-like particle system identifies the endonuclease domain of Crimean-Congo hemorrhagic fever virus. J. Virol. 2015, 89, 5957-5967. [CrossRef] [PubMed]
26. Bergeron, E, Albariño, C.G, Khristova, M.L, Nichol, S.T. Crimean-Congo hemorrhagic fever virus-encoded ovarian tumor protease activity is dispensable for virus RNA polymerase function. J. Virol. 2010, 84, 216-226. [CrossRef] [PubMed]
27. Zivcec, M, Metcalfe, M.G, Albariño, C.G, Guerrero, L.W, Pegan, S.D, Spiropoulou, C.F, Bergeron, É. Assessment of inhibitors of pathogenic Crimean-Congo hemorrhagic fever virus strains using virus-like particles. PLoS Negl. Trop. Dis. 2015, 9, e0004259. [CrossRef] [PubMed]
28. Barnwal, B, Karlberg, H, Mirazimi, A, Tan, Y.-J. Non-structural protein of Crimean-Congo hemorrhagic fever virus disrupts mitochondrial membrane potential and induces apoptosis. J. Biol. Chem. 2015, 291, 582-592. [CrossRef] [PubMed]
29. Albariño, C.G, Bird, B.H, Nichol, S.T. A shared transcription termination signal on negative and ambisense RNA genome segments of Rift Valley fever, sandfly fever Sicilian, and Toscana viruses. J. Virol. 2007, 81, 5246-5256. [CrossRef] [PubMed]
30. Pinschewer, D.D, Perez, M, de La Torre, J.C. Dual role of the lymphocytic choriomeningitis virus intergenic region in transcription termination and virus propagation. J. Virol. 2005, 79, 4519-4526. [CrossRef] [PubMed]
31. Sanchez, A.J, Vincent, M.J, Nichol, S.T. Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus. J. Virol. 2002, 76, 7263-7275. [CrossRef] [PubMed]
32. Zhou, Z.-R, Wang, M.-L, Deng, F, Li, T.-X, Hu, Z.-H, Wang, H.-L. Production of CCHF virus-like particle by a baculovirus-insect cell expression system. Virol. Sin. 2011, 26, 338-346. [CrossRef] [PubMed]
33. Joubert, J.R, King, J.B, Rossouw, D.J, Cooper, R. A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital Part III. Clinical pathology and pathogenesis. S. Afr. Med. J. 1985, 68, 722-728. [PubMed]
34. Hardestam, J, Simon, M, Hedlund, K.O, Vaheri, A, Klingström, J, Lundkvist, A. Ex vivo stability of the rodent-borne Hantaan virus in comparison to that of arthropod-borne members of the Bunyaviridae family. Appl. Environ. Microbiol. 2007, 73, 2547-2551. [CrossRef] [PubMed]
35. Korolev, M.B, Donets, M.A, Rubin, S.G, Chumakov, M.P. Morphology and morphogenesis of Crimean hemorrhagic fever virus. Arch. Virol. 1976, 50, 169-172. [CrossRef] [PubMed]
36. Donets, M.A, Chumakov, M.P, Korolev, M.B, Rubin, S.G. Physicochemical characteristics, morphology and morphogenesis of virions of the causative agent of Crimean hemorrhagic fever. Intervirology 1977, 8, 294-308. [CrossRef] [PubMed]
37. Bertolotti-ciarlet, A, Smith, J, Strecker, K, Paragas, J, Altamura, L.A, Mcfalls, J.M, Frias-sta, N, Schmaljohn, C.S, Doms, R.W. Cellular localization and antigenic characterization of Crimean-Congo hemorrhagic fever virus glycoproteins. J. Virol. 2005, 79, 6152-6161. [CrossRef] [PubMed]
38. Garry, C.E, Garry, R.F. Proteomics computational analyses suggest that the carboxyl terminal glycoproteins of Bunyaviruses are class II viral fusion protein (beta-penetrenes). Theor. Biol. Med. Model. 2004, 1, 10. [CrossRef] [PubMed]
39. Dessau, M, Modis, Y. Crystal structure of glycoprotein C from Rift Valley fever virus. Proc. Natl. Acad. Sci. USA 2013, 110, 1696-1701. [CrossRef] [PubMed]
40. Xiao, X, Feng, Y, Zhu, Z, Dimitrov, D.S. Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor. Biochem. Biophys. Res. Commun. 2011, 411, 253-258. [CrossRef] [PubMed]
41. Tayyari, F, Marchant, D, Moraes, T.J, Duan, W, Mastrangelo, P, Hegele, R.G. Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat. Med. 2011, 17, 1132-1135. [CrossRef] [PubMed]
42. Thongtan, T, Wikan, N, Wintachai, P, Rattanarungsan, C, Srisomsap, C, Cheepsunthorn, P, Smith, D.R. Characterization of putative Japanese encephalitis virus receptor molecules on microglial cells. J. Med. Virol. 2012, 84, 615-623. [CrossRef] [PubMed]
43. Tajrishi, M.M, Tuteja, R, Tuteja, N. Nucleolin: The most abundant multifunctional phosphoprotein of nucleolus. Commun. Integr. Biol. 2011, 4, 267-275. [CrossRef] [PubMed]
44. Ueno, T, Tokunaga, K, Sawa, H, Maeda, M, Chiba, J, Kojima, A, Hasegawa, H, Shoya, Y, Sata, T, Kurata, T, et al. Nucleolin and the packaging signal, psi, promote the budding of human immunodeficiency virus type-1 (HIV-1). Microbiol. Immunol. 2004, 48, 111-118. [CrossRef] [PubMed]
45. Simon, M, Johansson, C, Mirazimi, A. Crimean-Congo hemorrhagic fever virus entry and replication is clathrin-, pH- and cholesterol-dependent. J. Gen. Virol. 2009, 90, 210-215. [CrossRef] [PubMed]
46. Garrison, A.R, Radoshitzky, S.R, Kota, K.P, Pegoraro, G, Ruthel, G, Kuhn, J.H, Altamura, L.A, Kwilas, S.A, Bavari, S, Haucke, V, et al. Crimean-Congo hemorrhagic fever virus utilizes a clathrin- and early endosome-dependent entry pathway. Virology 2013, 444, 45-54. [CrossRef] [PubMed]
47. Shtanko, O, Nikitina, R.A, Altuntas, C.Z, Chepurnov, A.A, Davey, R.A. Crimean-Congo hemorrhagic fever virus entry into host cells occurs through the multivesicular body and requires ESCRT regulators. PLoS Pathog. 2014, 10, e1004390. [CrossRef] [PubMed]
48. Morin, B, Coutard, B, Lelke, M, Ferron, F, Kerber, R, Jamal, S, Frangeul, A, Baronti, C, Charrel, R, de Lamballerie, X, et al. The N-terminal domain of the arenavirus L protein is an RNA endonuclease essential in mRNA transcription. PLoS Pathog. 2010, 6, e1001038. [CrossRef] [PubMed]
49. Reguera, J, Weber, F, Cusack, S. Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription. PLoS Pathog. 2010, 6, e10011101. [CrossRef] [PubMed]
50. Dias, A, Bouvier, D, Crépin, T, McCarthy, A.A, Hart, D.J, Baudin, F, Cusack, S, Ruigrok, R.W.H. The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature 2009, 458, 914-918. [CrossRef] [PubMed]
51. Sanchez, A.J, Vincent, M.J, Erickson, B.R, Nichol, S.T. Crimean-Congo hemorrhagic fever virus glycoprotein precursor is cleaved by Furin-like and SKI-1 proteases to generate a novel 38-kilodalton glycoprotein. J. Virol. 2006, 80, 514-525. [CrossRef] [PubMed]
52. Altamura, L.A, Bertolotti-Ciarlet, A, Teigler, J, Paragas, J, Schmaljohn, C.S, Doms, R.W. Identification of a novel C-terminal cleavage of Crimean-Congo hemorrhagic fever virus PreGN that leads to generation of an NSM protein. J. Virol. 2007, 81, 6632-6642. [CrossRef] [PubMed]
53. Estrada, D.F, De Guzman, R.N. Structural characterization of the Crimean-Congo hemorrhagic fever virus Gn tail provides insight into virus assembly. J. Biol. Chem. 2011, 286, 21678-21686. [CrossRef] [PubMed]
54. Bergeron, E, Vincent, M.J, Nichol, S.T. Crimean-Congo hemorrhagic fever virus glycoprotein processing by the endoprotease SKI-1/S1P is critical for virus infectivity. J. Virol. 2007, 81, 13271-13276. [CrossRef] [PubMed]
55. Erickson, B.R, Deyde, V, Sanchez, A.J, Vincent, M.J, Nichol, S.T. N-linked glycosylation of Gn (but not Gc) is important for Crimean Congo hemorrhagic fever virus glycoprotein localization and transport. Virology 2007, 361, 348-355. [CrossRef] [PubMed]
56. Bergeron, É, Zivcec, M, Chakrabarti, A.K, Nichol, S.T, Albariño, C.G, Spiropoulou, C.F. Recovery of recombinant Crimean Congo hemorrhagic fever virus reveals a function for non-structural glycoproteins cleavage by furin. PLoS Pathog. 2015, 11, e1004879. [CrossRef] [PubMed]
57. Haferkamp, S, Fernando, L, Schwarz, T.F, Feldmann, H, Flick, R. Intracellular localization of Crimean-Congo hemorrhagic fever (CCHF) virus glycoproteins. Virol. J. 2005, 2, 42. [CrossRef] [PubMed]
58. Vincent, M.J, Sanchez, A.J, Erickson, B.R, Basak, A, Chretien, M, Seidah, N.G, Nichol, S.T. Crimean-Congo hemorrhagic fever virus glycoprotein proteolytic processing by subtilase SKI-1. J. Virol. 2003, 77, 8640-8649. [CrossRef] [PubMed]
59. Pasquato, A, de Palma, J.R, Galan, C, Seidah, N.G, Kunz, S. Viral envelope glycoprotein processing by proprotein convertases. Antivir. Res. 2013, 99, 49-60. [CrossRef] [PubMed]
60. Rojek, J.M, Lee, A.M, Nguyen, N, Spiropoulou, C.F, Kunz, S. Site 1 protease is required for proteolytic processing of the glycoproteins of the South American hemorrhagic fever viruses Junin, Machupo, and Guanarito. J. Virol. 2008, 82, 6045-6051. [CrossRef] [PubMed]
61. Andersson, I, Simon, M, Lundkvist, A, Nilsson, M, Holmström, A, Elgh, F, Mirazimi, A. Role of actin filaments in targeting of Crimean Congo hemorrhagic fever virus nucleocapsid protein to perinuclear regions of mammalian cells. J. Med. Virol. 2004, 72, 83-93. [CrossRef] [PubMed]
62. Andersson, I, Bladh, L, Mousavi-jazi, M, Magnusson, K, Lundkvist, A, Haller, O, Mirazimi, A. Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus. J. Virol. 2004, 78, 4323-4329. [CrossRef] [PubMed]
63. Connolly-Andersen, A.M, Magnusson, K.E, Mirazimi, A. Basolateral entry and release of Crimean-Congo hemorrhagic fever virus in polarized MDCK-1 cells. J. Virol. 2007, 81, 2158-2164. [CrossRef] [PubMed]
64. Macleod, J.M.L, Marmor, H, García-Sastre, A, Frias-Staheli, N. Mapping of the interaction domains of the Crimean-Congo hemorrhagic fever virus nucleocapsid protein. J. Gen. Virol. 2015, 96, 524-537. [CrossRef] [PubMed]
65. Carter, S.D, Surtees, R, Walter, C.T, Ariza, A, Bergeron, É, Nichol, S.T, Hiscox, J.A, Edwards, T.A, Barr, J.N. Structure, function, and evolution of the Crimean-Congo hemorrhagic fever virus nucleocapsid protein. J. Virol. 2012, 86, 10914-10923. [CrossRef] [PubMed]
66. Wang, W, Liu, X, Wang, X, Dong, H, Ma, C, Wang, J, Liu, B, Mao, Y, Wang, Y, Li, T, et al. Structural and functional diversity of nairovirus-encoded nucleoproteins. J. Virol. 2015, 89, 11740-11749. [CrossRef] [PubMed]
67. Guo, Y, Wang, W, Ji, W, Deng, M, Sun, Y, Zhou, H, Yang, C, Deng, F, Wang, H, Hu, Z, et al. Crimean-Congo hemorrhagic fever virus nucleoprotein reveals endonuclease activity in bunyaviruses. Proc. Natl. Acad. Sci. USA 2012, 109, 5046-5051. [CrossRef] [PubMed]
68. Hastie, K.M, Liu, T, Li, S, King, L.B, Ngo, N, Zandonatti, M.A, Woods, V.L, de la Torre, J.C, Saphire, E.O. Crystal structure of the Lassa virus nucleoprotein-RNA complex reveals a gating mechanism for RNA binding. Proc. Natl. Acad. Sci. USA 2011, 108, 19365-19370. [CrossRef] [PubMed]
69. Qi, X, Lan, S, Wang, W, Schelde, L.M, Dong, H, Wallat, G.D, Ly, H, Liang, Y, Dong, C. Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature 2010, 468, 779-783. [CrossRef] [PubMed]
70. Raymond, D.D, Piper, M.E, Gerrard, S.R, Smith, J.L. Structure of the Rift Valley fever virus nucleocapsid protein reveals another architecture for RNA encapsidation. Proc. Natl. Acad. Sci. USA 2010, 107, 11769-11774. [CrossRef] [PubMed]
71. Olal, D, Dick, A, Woods, V.L, Liu, T, Li, S, Devignot, S, Weber, F, Saphire, E.O, Daumke, O. Structural insights into RNA encapsidation and helical assembly of the Toscana virus nucleoprotein. Nucleic Acids Res. 2014, 42, 6025-6037. [CrossRef] [PubMed]
72. Reguera, J, Malet, H, Weber, F, Cusack, S. Structural basis for encapsidation of genomic RNA by La Crosse Orthobunyavirus nucleoprotein. Proc. Natl. Acad. Sci. USA 2013, 110, 7246-7251. [CrossRef] [PubMed]
73. Wang, Y, Dutta, S, Karlberg, H, Devignot, S, Weber, F, Hao, Q, Tan, Y.J, Mirazimi, A, Kotaka, M. Structure of Crimean-Congo hemorrhagic fever virus nucleoprotein: Superhelical homo-oligomers and the role of caspase-3 cleavage. J. Virol. 2012, 86, 12294-12303. [CrossRef] [PubMed]
74. Burt, F.J, Swanepoel, R, Braack, L.E.O. Enzyme-linked immunosorbent assays for the detection of antibody to Crimean-Congo haemorrhagic fever virus in the sera of livestock and wild vertebrates. Epidemiol. Infect. 2009, 111, 547-558. [CrossRef]
75. Burt, F.J, Samudzi, R.R, Randall, C, Pieters, D, Vermeulen, J, Knox, C.M. Human defined antigenic region on the nucleoprotein of Crimean-Congo hemorrhagic fever virus identified using truncated proteins and a bioinformatics approach. J. Virol. Methods 2013, 193, 706-712. [CrossRef] [PubMed]
76. Wei, P, Luo, Y, Li, T, Wang, H, Hu, Z, Zhang, F, Zhang, Y, Deng, F, Sun, S. Serial expression of the truncated fragments of the nucleocapsid protein of CCHFV and identification of the epitope region. Virol. Sin. 2010, 25, 45-51. [CrossRef] [PubMed]
77. Mousavi-Jazi, M, Karlberg, H, Papa, A, Christova, I, Mirazimi, A. Healthy individuals’ immune response to the Bulgarian Crimean-Congo hemorrhagic fever virus vaccine. Vaccine 2012, 30, 6225-6229. [CrossRef] [PubMed]
78. Levine, J.R, Prescott, J, Brown, K.S, Best, S.M, Ebihara, H, Feldmann, H. Antagonism of type I interferon responses by new world hantaviruses. J. Virol. 2010, 84, 11790-11801. [CrossRef] [PubMed]
79. Karlberg, H, Tan, Y.J, Mirazimi, A. Crimean-Congo haemorrhagic fever replication interplays with regulation mechanisms of apoptosis. J. Gen. Virol. 2015, 96, 538-546. [CrossRef] [PubMed]
80. Karlberg, H, Tan, Y.-J, Mirazimi, A. Induction of caspase activation and cleavage of the viral nucleocapsid protein in different cell types during Crimean-Congo hemorrhagic fever virus infection. J. Biol. Chem. 2011, 286, 3227-3234. [CrossRef] [PubMed]
81. Wolff, S, Becker, S, Groseth, A. Cleavage of the Junin virus nucleoprotein serves a decoy function to inhibit the induction of apoptosis during infection. J. Virol. 2013, 87, 224-233. [CrossRef] [PubMed]
82. Volchkov, V.E, Feldmann, H, Volchkova, V.A, Klenk, H.D. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc. Natl. Acad. Sci. USA 1998, 95, 5762-5767. [CrossRef] [PubMed]
83. Volchkov, V.E, Volchkova, V.A, Ströher, U, Becker, S, Dolnik, O, Cieplik, M, Garten, W, Klenk, H.D, Feldmann, H. Proteolytic processing of Marburg virus glycoprotein. Virology 2000, 268, 1-6. [CrossRef] [PubMed]
84. Fusco, M.L, Hashiguchi, T, Cassan, R, Biggins, J.E, Murin, C.D, Warfield, K.L, Li, S, Holtsberg, F.W, Shulenin, S, Vu, H, et al. Protective mAbs and cross-reactive mAbs raised by immunization with engineered marburg virus GPs. PLoS Pathog. 2015, 11, e1005016.
85. Honig, J.E, Osborne, J.C, Nichol, S.T. Crimean-Congo hemorrhagic fever virus genome L RNA segment and encoded protein. Virology 2004, 321, 29-35. [CrossRef] [PubMed]
86. Kinsella, E, Martin, S.G, Grolla, A, Czub, M, Feldmann, H, Flick, R. Sequence determination of the Crimean-Congo hemorrhagic fever virus L segment. Virology 2004, 321, 23-28. [CrossRef] [PubMed]
87. Habjan, M, Andersson, I, Klingström, J, Schümann, M, Martin, A, Zimmermann, P, Wagner, V, Pichlmair, A, Schneider, U, Mühlberger, E, et al. Processing of genome 51 termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS ONE 2008, 3, 1-8. [CrossRef] [PubMed]
88. Spengler, J.R, Patel, J.R, Chakrabarti, A.K, Zivcec, M, García-Sastre, A, Spiropoulou, C.F, Bergeron, E. RIG-I mediates an antiviral response to Crimean-Congo hemorrhagic fever virus. J. Virol. 2015, 89, 10119-10229. [CrossRef] [PubMed]
89. Garcin, D, Lezzi, M, Dobbs, M, Elliott, R.M, Schmaljohn, C, Kang, C.Y, Kolakofsky, D. The 51 ends of Hantaan virus (Bunyaviridae) RNAs suggest a prime-and-realign mechanism for the initiation of RNA synthesis. J. Virol. 1995, 69, 5754-5762. [PubMed]
90. Yao, H, Dittmann, M, Peisley, A, Hoffmann, H.H, Gilmore, R.H, Schmidt, T, Schmid-Burgk, J.L, Hornung, V, Rice, C.M, Hur, S. ATP-Dependent effector-like functions of RIG-I-like receptors. Mol. Cell 2015, 58, 541-548. [CrossRef] [PubMed]
91. Lee, M.-H, Lalwani, P, Raftery, M.J, Matthaei, M, Lutteke, N, Kirsanovs, S, Binder, M, Ulrich, R.G, Giese, T, Wolff, T, et al. RNA helicase retinoic acid-inducible gene I (RIG-I) as a sensor of Hantaan virus (HTNV) replication. J. Gen. Virol. 2011, 92, 2191-2200. [CrossRef] [PubMed]
92. Frias-Staheli, N, Giannakopoulos, N.V, Kikkert, M, Taylor, S.L, Bridgen, A, Paragas, J, Richt, J.A, Rowland, R.R, Schmaljohn, C.S, Lenschow, D.J, et al. Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe 2007, 2, 404-416. [CrossRef] [PubMed]
93. James, T.W, Frias-Staheli, N, Bacik, J.-P, Levingston Macleod, J.M, Khajehpour, M, García-Sastre, A, Mark, B.L. Structural basis for the removal of ubiquitin and interferon-stimulated gene 15 by a viral ovarian tumor domain-containing protease. Proc. Natl. Acad. Sci. USA 2011, 108, 2222-2227. [CrossRef] [PubMed]
94. Van Kasteren, P.B, Beugeling, C, Ninaber, D.K, Frias-Staheli, N, van Boheemen, S, García-Sastre, A, Snijder, E.J, Kikkert, M. Arterivirus and nairovirus ovarian tumor domain-containing Deubiquitinases target activated RIG-I to control innate immune signaling. J. Virol. 2012, 86, 773-785. [CrossRef] [PubMed]
95. Makarova, K. A novel superfamily of predicted cysteine proteases from eukaryotes, viruses and Chlamydia pneumoniae. Trends Biochem. Sci. 2000, 25, 50-52. [CrossRef]
96. Holzer, B, Bakshi, S, Bridgen, A, Baron, M.D. Inhibition of interferon induction and action by the nairovirus Nairobi sheep disease virus/Ganjam virus. PLoS ONE 2011, 6, e28594. [CrossRef] [PubMed]
97. Mielech, A.M, Kilianski, A, Baez-Santos, Y.M, Mesecar, A.D, Baker, S.C. MERS-CoV papain-like protease has deISGylating and deubiquitinating activities. Virology 2014, 450, 64-70. [CrossRef] [PubMed]
98. Zheng, D, Chen, G, Guo, B, Cheng, G, Tang, H. PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production. Cell Res. 2008, 18, 1105-1113. [PubMed]
99. Clementz, M.A, Chen, Z, Banach, B.S, Wang, Y, Sun, L, Ratia, K, Baez-Santos, Y.M, Wang, J, Takayama, J, Ghosh, A.K, et al. Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. J. Virol. 2010, 84, 4619-4629. [CrossRef] [PubMed]
100. Zhang, H.-M, Yang, J, Sun, H.-R, Xin, X, Wang, H.-D, Chen, J.-P, Adams, M.J. Genomic analysis of rice stripe virus Zhejiang isolate shows the presence of an OTU-like domain in the RNA1 protein and a novel sequence motif conserved within the intergenic regions of ambisense segments of tenuiviruses. Arch. Virol. 2007, 152, 1917-1923. [CrossRef] [PubMed]
101. Lombardi, C, Ayach, M, Beaurepaire, L, Chenon, M, Andreani, J, Guerois, R, Jupin, I, Bressanelli, S. A compact viral processing proteinase/ubiquitin hydrolase from the OTU family. PLoS Pathog. 2013, 9, e1003560. [CrossRef] [PubMed]
102. Kayagaki, N, Phung, Q, Chan, S, Chaudhari, R, Quan, C, O’Rourke, K.M, Eby, M, Pietras, E, Cheng, G, Bazan, J.F, et al. DUBA: A deubiquitinase that regulates type I interferon production. Science 2007, 318, 1628-1632. [CrossRef] [PubMed]
103. Jiang, X, Kinch, L.N, Brautigam, C.A, Chen, X, Du, F, Grishin, N.V, Chen, Z.J. Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response. Immunity 2012, 36, 973-959. [CrossRef] [PubMed]
104. Zhao, C, Denison, C, Huibregtse, J.M, Gygi, S, Krug, R.M. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc. Natl. Acad. Sci. USA 2005, 102, 10200-10205. [CrossRef] [PubMed]
105. Okumura, F, Okumura, A.J, Uematsu, K, Hatakeyama, S, Zhang, D.E, Kamura, T. Activation of double-stranded RNA-activated protein kinase (PKR) by interferon-stimulated gene 15 (ISG15) modification down-regulates protein translation. J. Biol. Chem. 2013, 288, 2839-2847. [CrossRef] [PubMed]
106. Wang, P, Zhao, W, Zhao, K, Zhang, L, Gao, C. TRIM26 negatively regulates interferon-β production and antiviral response through polyubiquitination and degradation of nuclear IRF3. PLoS Pathog. 2015, 11, e1004726. [CrossRef] [PubMed]
107. Shi, H.-X, Yang, K, Liu, X, Liu, X.-Y, Wei, B, Shan, Y.-F, Zhu, L.-H, Wang, C. Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification. Mol. Cell. Biol. 2010, 30, 2424-2436. [CrossRef] [PubMed]
108. Giannakopoulos, N.V, Luo, J.-K, Papov, V, Zou, W, Lenschow, D.J, Jacobs, B.S, Borden, E.C, Li, J, Virgin, H.W, Zhang, D.-E. Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem. Biophys. Res. Commun. 2005, 336, 496-506. [CrossRef] [PubMed]
109. Akutsu, M, Ye, Y, Virdee, S, Chin, J.W, Komander, D. Molecular basis for ubiquitin and ISG15 cross-reactivity in viral ovarian tumor domains. Proc. Natl. Acad. Sci. USA 2011, 108, 2228-2233. [CrossRef] [PubMed]
110. Capodagli, G.C, McKercher, M.A, Baker, E.A, Masters, E.M, Brunzelle, J.S, Pegan, S.D. Structural analysis of a viral ovarian tumor domain protease from the Crimean-Congo hemorrhagic fever virus in complex with covalently bonded ubiquitin. J. Virol. 2011, 85, 3621-3630. [CrossRef] [PubMed]
111. Kim, M.-J, Hwang, S.-Y, Imaizumi, T, Yoo, J.-Y. Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J. Virol. 2008, 82, 1474-1483. [CrossRef] [PubMed]
112. Kohl, A, Dunn, E.F, Lowen, A.C, Elliott, R.M. Complementarity, sequence and structural elements within the 31 and 51 non-coding regions of the Bunyamwera orthobunyavirus S segment determine promoter strength. J. Gen. Virol. 2004, 85, 3269-3278. [CrossRef] [PubMed]
113. Barr, J.N, Wertz, G.W. Role of the conserved nucleotide mismatch within 31- and 51-terminal regions of Bunyamwera virus in signaling transcription. J. Virol. 2005, 79, 3586-3594. [CrossRef] [PubMed]
114. Duygu, F, Kaya, T, Baysan, P. Re-evaluation of 400 Crimean-Congo hemorrhagic fever cases in an endemic area: Is ribavirin treatment suitable? Vector Borne Zoonotic Dis. 2012, 12, 812-816. [CrossRef] [PubMed]
115. Koksal, I, Yilmaz, G, Aksoy, F, Aydin, H, Yavuz, I, Iskender, S, Akcay, K, Erensoy, S, Caylan, R, Aydin, K. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey. J. Clin. Virol. 2010, 47, 65-68. [CrossRef] [PubMed]
116. Soares-Weiser, K, Thomas, S, Thomson, G, Garner, P. Ribavirin for Crimean-Congo hemorrhagic fever: Systematic review and meta-analysis. BMC Infect. Dis. 2010, 10, 207. [CrossRef] [PubMed]
117. Bell-Sakyi, L, Kohl, A, Bente, D.A, Fazakerley, J.K. Tick cell lines for study of Crimean-Congo hemorrhagic fever virus and other arboviruses. Vector Borne Zoonotic Dis. 2012, 12, 769-781. [CrossRef] [PubMed]
118. Gargili, A, Thangamani, S, Bente, D. Influence of laboratory animal hosts on the life cycle of Hyalomma marginatum and implications for an in vivo transmission model for Crimean-Congo hemorrhagic fever virus. Front. Cell. Infect. Microbiol. 2013, 3, 39. [CrossRef] [PubMed]
119. Bente, D.A, Alimonti, J.B, Shieh, W.-J, Camus, G, Ströher, U, Zaki, S, Jones, S.M. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J. Virol. 2010, 84, 11089-11100. [CrossRef] [PubMed]
120. Oestereich, L, Rieger, T, Neumann, M, Bernreuther, C, Lehmann, M, Krasemann, S, Wurr, S, Emmerich, P, de Lamballerie, X, Ölschläger, S, et al. Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever. PLoS Negl. Trop. Dis. 2014, 8, e2804. [CrossRef] [PubMed]
121. Dowall, S.D, Buttigieg, K.R, Findlay-Wilson, S.J.D, Rayner, E, Pearson, G, Miloszewska, A, Graham, V.A, Carroll, M, Hewson, R. A Crimean-Congo Haemorrhagic Fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease. Hum. Vaccin. Immunother. 2016. [CrossRef] [PubMed]
122. Kortekaas, J, Vloet, R.P.M, McAuley, A.J, Shen, X, Bosch, B.J, de Vries, L, Moormann, R.J.M, Bente, D.A. Crimean-Congo hemorrhagic fever virus subunit vaccines induce high levels of neutralizing Antibodies but no protection in STAT1 knockout mice. Vector Borne Zoonotic Dis. 2015, 15, 759-764. [CrossRef] [PubMed]
123. Canakoglu, N, Berber, E, Tonbak, S, Ertek, M, Sozdutmaz, I, Aktas, M, Kalkan, A, Ozdarendeli, A. Immunization of knock-out α/β interferon receptor mice against high lethal dose of Crimean-Congo hemorrhagic fever virus with a cell culture based vaccine. PLoS Negl. Trop. Dis. 2015, 11, e0003579. [CrossRef] [PubMed]
124. Buttigieg, K.R, Dowall, S.D, Findlay-Wilson, S, Miloszewska, A, Rayner, E, Hewson, R, Carroll, M.W. A novel vaccine against Crimean-Congo haemorrhagic fever protects 100% of animals against lethal challenge in a mouse model. PLoS ONE 2014, 9, e91596. [CrossRef] [PubMed]
125. Andersson, I, Lundkvist, Å, Haller, O, Mirazimi, A. Type I Interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cells. J. Med. Virol. 2006, 222, 216-222. [CrossRef] [PubMed]